DE60231406D1 - Isotone Fettemulsionen - Google Patents

Isotone Fettemulsionen

Info

Publication number
DE60231406D1
DE60231406D1 DE60231406T DE60231406T DE60231406D1 DE 60231406 D1 DE60231406 D1 DE 60231406D1 DE 60231406 T DE60231406 T DE 60231406T DE 60231406 T DE60231406 T DE 60231406T DE 60231406 D1 DE60231406 D1 DE 60231406D1
Authority
DE
Germany
Prior art keywords
fat emulsions
organs
tissues
cell membranes
isotonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231406T
Other languages
English (en)
Inventor
Yvon Carpentier
Isabelle Dupont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carpentier Yovn Prof Bruessel Be
Sofronis Nikolas Grand Duche De Luxembourg Lu
Winand Jacques Prof Bruessel Be
Original Assignee
TARGET HIT SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TARGET HIT SA filed Critical TARGET HIT SA
Application granted granted Critical
Publication of DE60231406D1 publication Critical patent/DE60231406D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60231406T 2001-07-25 2002-07-20 Isotone Fettemulsionen Expired - Lifetime DE60231406D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01117991A EP1279400A1 (de) 2001-07-25 2001-07-25 Änderung der Fettsäurezusammensetzung Organ- und Gewebe-Zellmembranen
PCT/EP2002/008121 WO2003009828A1 (en) 2001-07-25 2002-07-20 Modifying the fatty acid composition of cell membranes of organs and tissues

Publications (1)

Publication Number Publication Date
DE60231406D1 true DE60231406D1 (de) 2009-04-16

Family

ID=8178132

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231406T Expired - Lifetime DE60231406D1 (de) 2001-07-25 2002-07-20 Isotone Fettemulsionen

Country Status (10)

Country Link
US (1) US7560486B2 (de)
EP (2) EP1279400A1 (de)
JP (1) JP2005501828A (de)
CN (1) CN1267085C (de)
AT (1) ATE424188T1 (de)
CA (1) CA2454665C (de)
DE (1) DE60231406D1 (de)
ES (1) ES2324526T3 (de)
IL (1) IL160012A0 (de)
WO (1) WO2003009828A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
WO2014130746A1 (en) * 2013-02-20 2014-08-28 The Trustees Of Columbia University In The City Of New York Use of an omega-3 lipid-based emulsion for protecting human organs from ischemic injury
US20070149617A1 (en) 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
EP1957039A2 (de) * 2005-12-09 2008-08-20 Drugtech Corporation Intravenöse essentielle fettsäurenemulsion
PT1800675E (pt) 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
WO2008147562A2 (en) * 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
WO2009046231A1 (en) 2007-10-03 2009-04-09 E. I. Du Pont De Nemours And Company Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
US8063020B2 (en) * 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
JP5498491B2 (ja) 2008-07-07 2014-05-21 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその栄養組成物の使用方法
EP2405902B1 (de) * 2009-03-09 2021-07-21 Basf As Zusammensetzungen mit einer fettsäureölmischung und einem tensid sowie verfahren und verwendung dafür
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
NZ601027A (en) 2010-01-04 2014-08-29 Pentec Health Inc Nutritive compositions and methods of using same
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
US20110200645A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Free Fatty Acid Emulsions
WO2012170633A1 (en) 2011-06-09 2012-12-13 Lifeline Scientific, Inc. Data record for organ transport and/or storage, comprising biomarker and events information
CN107028926A (zh) * 2011-08-26 2017-08-11 国立大学法人大阪大学 糖尿病性心血管并发症的预防/治疗剂
AU2013235266B2 (en) 2012-03-20 2017-10-19 Particle Dynamics International, Llc Gelling agent-based dosage form
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
US10070643B2 (en) 2013-03-28 2018-09-11 The Trustees Of Columbia University In The City Of New York Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
WO2015076830A1 (en) * 2013-11-22 2015-05-28 General Electric Company Fatty acid biodispersant and methods of use
EP3191091B1 (de) * 2014-09-12 2020-08-26 Children's Medical Center Corporation Formulierungen einer diätetischen emulsion und verfahren zur verwendung davon
CN106667910B (zh) * 2017-01-12 2021-02-02 西南大学 一种谷维素鱼油纳米乳液及其制备方法和应用
US11324697B2 (en) 2017-08-10 2022-05-10 The Children's Medical Center Corporation Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
EP4181876A1 (de) * 2020-07-14 2023-05-24 Nutrition Lipid Developments Isotonische lipidemulsion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049747A (ja) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk リン脂質組成物
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
DE3903056A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
DE3903057A1 (de) 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
JP4165904B2 (ja) 1995-11-28 2008-10-15 ベー・ブラウン・メルズンゲン・アクチエンゲゼルシャフト 加水分解最適化脂質エマルジョンおよびその使用

Also Published As

Publication number Publication date
CA2454665A1 (en) 2003-02-06
IL160012A0 (en) 2004-06-20
EP1279400A1 (de) 2003-01-29
CA2454665C (en) 2011-10-11
CN1553798A (zh) 2004-12-08
WO2003009828A1 (en) 2003-02-06
EP1408931B1 (de) 2009-03-04
US20040247693A1 (en) 2004-12-09
ES2324526T3 (es) 2009-08-10
ATE424188T1 (de) 2009-03-15
JP2005501828A (ja) 2005-01-20
US7560486B2 (en) 2009-07-14
EP1408931A1 (de) 2004-04-21
CN1267085C (zh) 2006-08-02

Similar Documents

Publication Publication Date Title
DE60231406D1 (de) Isotone Fettemulsionen
DE602004031750D1 (de) Frauenmilch-lipid-mimitikum als nahrungsmittelzusatz
DE60114606D1 (de) Ausgewogene lipidzusammensetzung enthaltende eier
WO2008005869A3 (en) Infant formulas for early brain development
BR0110664A (pt) Composição de gordura alimentìcia escoável, e, uso de uma combinação de um éster de ácido cìtrico de glicerìdeos parciais de ácido graxo e um sal
PE20070999A1 (es) Emulsion de acido graso esencial intravenosa
DE69816568D1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
TW200612834A (en) Acidic oil-in-water emulsion composition
ATE443515T1 (de) Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
NO20040684L (no) Liptidblandinger og naeringsmiddelprodukter som inneholder oljefettsyre og omega-6-fettsyrer, laget for a oke det intramyocellulaere lipidnivaet
CR6807A (es) Subtipos de almidon y metabolismo de lipidos
DE60226257D1 (de) Schäumende emulsionen des öl-in-wasser-typs und verfahren zu ihrer herstellung
RS52735B (en) APPLICATION OF A COMBINATION CONTAINING L-CARNITINE OR ALKANOIL L-CARNITINE, OIL-SOLUBLE OIL-BENZOQUINON AND OMEGA-3-POLYESATURATED FATTY ACID FOR PREPARATION OF NUTRITION OR MEDICINAL PRODUCTS
DK0790056T3 (da) Anvendelse af præparat til forebyggelse eller behandling af sygdomme forårsaget af abnormiteter i bruskvæv
RU2006105335A (ru) Mvl-косметика
Stark et al. Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid compositions⃞
BRPI0401751B1 (pt) Pacote de agente tensoativo e emulsão de água-em-hidrocarboneto utilizando o mesmo
WO2002092779A3 (en) Method for enriching tissues in long chain polyunsaturated fatty acids
WO1999066922A8 (en) Method of altering nutritional components of milk produced by a lactating animal
FI980961A (fi) Menetelmä märehtijän maito- ja/tai kudosrasvan konjugoidun linolihaponpitoisuuden nostamiseksi
Zimmer et al. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex
DK1419699T3 (da) Levnedsmidler indeholdende fedt og salt
ATE402695T1 (de) Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
DE69809743T2 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
BRPI0401181A (pt) Composições, processo para colorir as fibras queratìnicas humanas, processo para colorir pele escura, dispositivo com vários compartimentos e uso de uma composição

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CARPENTIER, YOVN, PROF., BRUESSEL, BE

Owner name: SOFRONIS, NIKOLAS, GRAND DUCHE DE LUXEMBOURG, LU

Owner name: WINAND, JACQUES, PROF., BRUESSEL, BE